{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:16:00Z","timestamp":1780514160968,"version":"3.54.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the ministry of health, labour and welfare of japan","award":["20FC1030"],"award-info":[{"award-number":["20FC1030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10072-021-05583-7","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:48Z","timestamp":1631793768000},"page":"4489-4501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Paraproteinemia and neuropathy"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-3183","authenticated-orcid":false,"given":"Haruki","family":"Koike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"3","key":"5583_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.blre.2015.12.001","volume":"30","author":"SV Glavey","year":"2016","unstructured":"Glavey SV, Leung N (2016) Monoclonal gammopathy: the good, the bad and the ugly. Blood Rev 30(3):223\u2013231","journal-title":"Blood Rev"},{"issue":"3","key":"5583_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, Rajkumar SV (2018) Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med 378(3):241\u2013249","journal-title":"N Engl J Med"},{"issue":"5","key":"5583_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.mayocp.2017.02.003","volume":"92","author":"HM Chaudhry","year":"2017","unstructured":"Chaudhry HM, Mauermann ML, Rajkumar SV (2017) Monoclonal gammopathy-associated peripheral neuropathy: diagnosis and management. Mayo Clin Proc 92(5):838\u2013850","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"5583_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/jcp.35.1.63","volume":"35","author":"JP Saleun","year":"1982","unstructured":"Saleun JP, Vicariot M, Deroff P, Morin JF (1982) Monoclonal gammopathies in the adult population of Finist\u00e8re. France J Clin Pathol 35(1):63\u201368","journal-title":"France J Clin Pathol"},{"issue":"1","key":"5583_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0002-9343(87)90375-5","volume":"82","author":"J Crawford","year":"1987","unstructured":"Crawford J, Eye MK, Cohen HJ (1987) Evaluation of monoclonal gammopathies in the \u201cwell\u201d elderly. Am J Med 82(1):39\u201345","journal-title":"Am J Med"},{"issue":"13","key":"5583_CR6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354(13):1362\u20131369","journal-title":"N Engl J Med"},{"issue":"5","key":"5583_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1212\/WNL.0000000000011324","volume":"96","author":"JM Vallat","year":"2021","unstructured":"Vallat JM, Duchesne M, Corcia P, Richard L, Ghorab K, Magy L, Mathis S (2021) The wide spectrum of pathophysiologic mechanisms of paraproteinemic neuropathy. Neurology 96(5):214\u2013225","journal-title":"Neurology"},{"issue":"11","key":"5583_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","volume":"31","author":"JJ Kelly Jr","year":"1981","unstructured":"Kelly JJ Jr, Kyle RA, O\u2019Brien PC, Dyck PJ (1981) Prevalence of monoclonal protein in peripheral neuropathy. Neurology 31(11):1480\u20131483","journal-title":"Neurology"},{"issue":"Pt 8","key":"5583_CR9","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1093\/brain\/awt193","volume":"136","author":"M Tomita","year":"2013","unstructured":"Tomita M, Koike H, Kawagashira Y, Iijima M, Adachi H, Taguchi J, Abe T, Sako K, Tsuji Y, Nakagawa M, Kanda F, Takeda F, Sugawara M, Toyoshima I, Asano N, Sobue G (2013) Clinicopathological features of neuropathy associated with lymphoma. Brain 136(Pt 8):2563\u20132578","journal-title":"Brain"},{"issue":"Suppl 1","key":"5583_CR10","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/ana.410370705","volume":"37","author":"N Latov","year":"1995","unstructured":"Latov N (1995) Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 37(Suppl 1):S32-42","journal-title":"Ann Neurol"},{"issue":"11","key":"5583_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/NEN.0b013e3181fa44af","volume":"69","author":"Y Kawagashira","year":"2010","unstructured":"Kawagashira Y, Koike H, Tomita M, Morozumi S, Iijima M, Nakamura T, Katsuno M, Tanaka F, Sobue G (2010) Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy. J Neuropathol Exp Neurol 69(11):1143\u20131157","journal-title":"J Neuropathol Exp Neurol"},{"key":"5583_CR12","doi-asserted-by":"publisher","first-page":"117305","DOI":"10.1016\/j.jns.2020.117305","volume":"421","author":"H Koike","year":"2021","unstructured":"Koike H, Mouri N, Fukami Y, Iijima M, Matsuo K, Yagi N, Saito A, Nakamura H, Takahashi K, Nakae Y, Okada Y, Tanaka F, Sobue G, Katsuno M (2021) Two distinct mechanisms of neuropathy in immunoglobulin light chain (AL) amyloidosis. J Neurol Sci 421:117305","journal-title":"J Neurol Sci"},{"issue":"10","key":"5583_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/jnnp.2007.135681","volume":"79","author":"H Koike","year":"2008","unstructured":"Koike H, Iijima M, Mori K, Yamamoto M, Hattori N, Watanabe H, Tanaka F, Doyu M, Sobue G (2008) Neuropathic pain correlates with myelinated fibre loss and cytokine profile in POEMS syndrome. J Neurol Neurosurg Psychiatry 79(10):1171\u20131179","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5583_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/WCO.0b013e32832fd563","volume":"22","author":"S Ramchandren","year":"2009","unstructured":"Ramchandren S, Lewis RA (2009) Monoclonal gammopathy and neuropathy. Curr Opin Neurol 22(5):480\u2013485","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"5583_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ana.410360313","volume":"36","author":"E Nobile-Orazio","year":"1994","unstructured":"Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L et al (1994) Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36(3):416\u2013424","journal-title":"Ann Neurol"},{"issue":"12","key":"5583_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/jnnp-2017-315736","volume":"88","author":"M Campagnolo","year":"2017","unstructured":"Campagnolo M, Zambello R, Nobile-Orazio E, Benedetti L, Marfia GA, Riva N, Castellani F, Bianco M, Salvalaggio A, Garnero M, Ruiz M, Mataluni G, Fazio R, Ermani M, Briani C (2017) IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy. J Neurol Neurosurg Psychiatry 88(12):1094\u20131097","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5583_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","volume":"89","author":"J Svahn","year":"2018","unstructured":"Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, L\u00e9ger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanch\u00e9 JP (2018) Francophone anti-MAG cohort Group. Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. J Neurol Neurosurg Psychiatry 89(5):499\u2013505","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5583_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/01.wco.0000245368.36576.0d","volume":"19","author":"AJ Steck","year":"2006","unstructured":"Steck AJ, Stalder AK, Renaud S (2006) Anti-myelin-associated glycoprotein neuropathy. Curr Opin Neurol 19(5):458\u2013463","journal-title":"Curr Opin Neurol"},{"issue":"Pt 4","key":"5583_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/brain\/awf072","volume":"125","author":"MP Lunn","year":"2002","unstructured":"Lunn MP, Crawford TO, Hughes RA, Griffin JW, Sheikh KA (2002) Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing. Brain 125(Pt 4):904\u2013911","journal-title":"Brain"},{"issue":"3","key":"5583_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1083\/jcb.92.3.877","volume":"92","author":"BD Trapp","year":"1982","unstructured":"Trapp BD, Quarles RH (1982) Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 92(3):877\u2013882","journal-title":"J Cell Biol"},{"issue":"3","key":"5583_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF00227726","volume":"85","author":"B Lach","year":"1993","unstructured":"Lach B, Rippstein P, Atack D, Afar DE, Gregor A (1993) Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta Neuropathol 85(3):298\u2013307","journal-title":"Acta Neuropathol"},{"issue":"5","key":"5583_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/jnen\/64.5.386","volume":"64","author":"JM Vallat","year":"2005","unstructured":"Vallat JM, Magy L, Sindou P, Magdelaine C, Cros D (2005) IgG neuropathy: an immunoelectron microscopic study. J Neuropathol Exp Neurol 64(5):386\u2013390","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"5583_CR23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/1531-8249(200006)47:6<808::AID-ANA15>3.0.CO;2-8","volume":"47","author":"JM Vallat","year":"2000","unstructured":"Vallat JM, Tabaraud F, Sindou P, Preux PM, Vandenberghe A, Steck A (2000) Myelin widenings and MGUS-IgA: an immunoelectron microscopic study. Ann Neurol 47(6):808\u2013811","journal-title":"Ann Neurol"},{"issue":"10","key":"5583_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJM199003083221002","volume":"322","author":"S Monaco","year":"1990","unstructured":"Monaco S, Bonetti B, Ferrari S, Moretto G, Nardelli E, Tedesco F, Mollnes TE, Nobile-Orazio E, Manfredini E, Bonazzi L et al (1990) Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 322(10):649\u2013652","journal-title":"N Engl J Med"},{"issue":"6","key":"5583_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","volume":"88","author":"H Koike","year":"2017","unstructured":"Koike H, Kadoya M, Kaida KI, Ikeda S, Kawagashira Y, Iijima M, Kato D, Ogata H, Yamasaki R, Matsukawa N, Kira JI, Katsuno M, Sobue G (2017) Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry 88(6):465\u2013473","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5583_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40120-020-00190-8","volume":"9","author":"H Koike","year":"2020","unstructured":"Koike H, Katsuno M (2020) Pathophysiology of chronic inflammatory demyelinating polyneuropathy: insights into classification and therapeutic strategy. Neurol Ther 9(2):213\u2013227","journal-title":"Neurol Ther"},{"issue":"12","key":"5583_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/jnen\/nlaa085","volume":"79","author":"Y Kawagashira","year":"2020","unstructured":"Kawagashira Y, Koike H, Takahashi M, Ohyama K, Iijima M, Katsuno M, Niwa JI, Doyu M, Sobue G (2020) Aberrant expression of nodal and paranodal molecules in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibodies. J Neuropathol Exp Neurol 79(12):1303\u20131312","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"5583_CR28","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/cells10040844","volume":"10","author":"H Koike","year":"2021","unstructured":"Koike H, Katsuno M (2021) Macrophages and autoantibodies in demyelinating diseases. Cells 10(4):844","journal-title":"Cells"},{"issue":"23","key":"5583_CR29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/WNL.0000000000006625","volume":"91","author":"H Koike","year":"2018","unstructured":"Koike H, Nishi R, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G (2018) Ultrastructural mechanisms of macrophage-induced demyelination in CIDP. Neurology 91(23):1051\u20131060","journal-title":"Neurology"},{"issue":"6","key":"5583_CR30","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","volume":"91","author":"H Koike","year":"2020","unstructured":"Koike H, Fukami Y, Nishi R, Kawagashira Y, Iijima M, Katsuno M, Sobue G (2020) Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry 91(6):650\u2013659","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"5583_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/mus.21741","volume":"42","author":"Y Kawagashira","year":"2010","unstructured":"Kawagashira Y, Kondo N, Atsuta N, Iijima M, Koike H, Katsuno M, Tanaka F, Kusunoki S, Sobue G (2010) IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy. Muscle Nerve 42(3):433\u2013435","journal-title":"Muscle Nerve"},{"key":"5583_CR32","doi-asserted-by":"crossref","unstructured":"Magy L, Kabor\u00e9 R, Mathis S, Lebeau P, Ghorab K, Caudie C, Vallat JM. 2015 Heterogeneity of polyneuropathy associated with anti-MAG antibodies. J Immunol Res. 2015:450391.","DOI":"10.1155\/2015\/450391"},{"key":"5583_CR33","unstructured":"Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA. European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force - Second Revision. J Peripher Nerv Syst.\u00a0in press."},{"issue":"Pt 5","key":"5583_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/brain\/117.5.941","volume":"117","author":"DA Kaku","year":"1994","unstructured":"Kaku DA, England JD, Sumner AJ (1994) Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 117(Pt 5):941\u2013947","journal-title":"Brain"},{"issue":"7","key":"5583_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mus.880180709","volume":"18","author":"W Trojaborg","year":"1995","unstructured":"Trojaborg W, Hays AP, van den Berg L, Younger DS, Latov N (1995) Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve 18(7):730\u2013735","journal-title":"Muscle Nerve"},{"issue":"3","key":"5583_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1388-2457(02)00011-1","volume":"113","author":"M Capasso","year":"2002","unstructured":"Capasso M, Torrieri F, Di Muzio A, De Angelis MV, Lugaresi A, Uncini A (2002) Can electrophysiology differentiate polyneuropathy with anti-MAG\/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? Clin Neurophysiol 113(3):346\u2013353","journal-title":"Clin Neurophysiol"},{"issue":"8","key":"5583_CR37","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/jnnp.2006.111930","volume":"78","author":"FA Gondim","year":"2007","unstructured":"Gondim FA, De Sousa EA, Latov N, Sander HW, Chin RL, Brannagan TH (2007) Anti-MAG\/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion. J Neurol Neurosurg Psychiatry 78(8):902\u2013904","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"5583_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11940-017-0479-9","volume":"19","author":"E Nobile-Orazio","year":"2017","unstructured":"Nobile-Orazio E, Bianco M, Nozza A (2017) Advances in the treatment of paraproteinemic neuropathy. Curr Treat Options Neurol 19(12):43","journal-title":"Curr Treat Options Neurol"},{"issue":"11","key":"5583_CR39","doi-asserted-by":"crossref","first-page":"175628561774664","DOI":"10.1177\/1756285617746640","volume":"15","author":"MC Dalakas","year":"2018","unstructured":"Dalakas MC (2018) Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies. Ther Adv Neurol Disord 15(11):1756285617746640","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"5583_CR40","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI58743","volume":"122","author":"MA Maurer","year":"2012","unstructured":"Maurer MA, Rakocevic G, Leung CS, Quast I, Luka\u010di\u0161in M, Goebels N, M\u00fcnz C, Wardemann H, Dalakas M, L\u00fcnemann JD (2012) Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. J Clin Invest 122(4):1393\u20131402","journal-title":"J Clin Invest"},{"issue":"3","key":"5583_CR41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ana.21577","volume":"65","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B (2009) Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 65(3):286\u2013293","journal-title":"Ann Neurol"},{"issue":"24","key":"5583_CR42","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","volume":"80","author":"JM L\u00e9ger","year":"2013","unstructured":"L\u00e9ger JM, Viala K, Nicolas G, Cr\u00e9ange A, Vallat JM, Pouget J, Clavelou P, Vial C, Steck A, Musset L, Marin B, RIMAG Study Group (2013) (France and Switzerland). Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy. Neurology 80(24):2217\u201325","journal-title":"Neurology"},{"issue":"8","key":"5583_CR43","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1212\/WNL.52.8.1701","volume":"52","author":"TD Levine","year":"1999","unstructured":"Levine TD, Pestronk A (1999) IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab. Neurology 52(8):1701\u20131704","journal-title":"Neurology"},{"issue":"1\u20132","key":"5583_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2014.11.006","volume":"348","author":"Y Kawagashira","year":"2015","unstructured":"Kawagashira Y, Koike H, Ohyama K, Hashimoto R, Iijima M, Adachi H, Katsuno M, Chapman M, Lunn M, Sobue G (2015) Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. J Neurol Sci 348(1\u20132):67\u201373","journal-title":"J Neurol Sci"},{"issue":"10","key":"5583_CR45","first-page":"CD002827","volume":"10","author":"MP Lunn","year":"2016","unstructured":"Lunn MP, Nobile-Orazio E (2016) Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 10(10):CD002827","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5583_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jns.12156","volume":"21","author":"R Iancu Ferfoglia","year":"2016","unstructured":"Iancu Ferfoglia R, Guimar\u00e3es-Costa R, Viala K, Musset L, Neil J, Marin B, L\u00e9ger JM (2016) Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study. J Peripher Nerv Syst 21(1):10\u201314","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"5583_CR47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/WNL.34.6.712","volume":"34","author":"T Nakanishi","year":"1984","unstructured":"Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, Tsubaki T, Igata A, Ozaki Y (1984) The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology 34(6):712\u2013720","journal-title":"Neurology"},{"issue":"7","key":"5583_CR48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","volume":"94","author":"A Dispenzieri","year":"2019","unstructured":"Dispenzieri A (2019) POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management. Am J Hematol 94(7):812\u2013827","journal-title":"Am J Hematol"},{"issue":"10","key":"5583_CR49","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1212\/WNL.0000000000008062","volume":"93","author":"T Suichi","year":"2019","unstructured":"Suichi T, Misawa S, Beppu M, Takahashi S, Sekiguchi Y, Shibuya K, Amino H, Tsuneyama A, Suzuki YI, Nakamura K, Sato Y, Kuwabara S (2019) Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey. Neurology 93(10):e975\u2013e983","journal-title":"Neurology"},{"key":"5583_CR50","doi-asserted-by":"publisher","first-page":"116771","DOI":"10.1016\/j.jns.2020.116771","volume":"413","author":"T Suichi","year":"2020","unstructured":"Suichi T, Misawa S, Sekiguchi Y, Shibuya K, Tsuneyama A, Suzuki YI, Nakamura K, Kano H, Kuwabara S (2020) Treatment response and prognosis of POEMS syndrome coexisting with Castleman disease. J Neurol Sci 413:116771","journal-title":"J Neurol Sci"},{"issue":"6","key":"5583_CR51","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/jnnp.64.6.809","volume":"64","author":"D Adams","year":"1998","unstructured":"Adams D, Said G (1998) Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome. J Neurol Neurosurg Psychiatry 64(6):809\u2013812","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9002","key":"5583_CR52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","volume":"347","author":"O Watanabe","year":"1996","unstructured":"Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347(9002):702","journal-title":"Lancet"},{"issue":"6","key":"5583_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1212\/WNL.0b013e318263c42b","volume":"79","author":"K Kanai","year":"2012","unstructured":"Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y, Nasu S, Nakaseko C, Takano S, Yoshitomi H, Miyazaki M, Nomura F, Kuwabara S (2012) Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology 79(6):575\u2013582","journal-title":"Neurology"},{"issue":"2","key":"5583_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00311391","volume":"84","author":"G Sobue","year":"1992","unstructured":"Sobue G, Doyu M, Watanabe M, Hayashi F, Mitsuma T (1992) Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Acta Neuropathol 84(2):171\u2013177","journal-title":"Acta Neuropathol"},{"issue":"3","key":"5583_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/BF00296746","volume":"87","author":"C Vital","year":"1994","unstructured":"Vital C, Gherardi R, Vital A, Kopp N, Pellissier JF, Soubrier M, Clavelou P, Bellance R, Delisle MB, Ruchoux MM et al (1994) Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol 87(3):302\u20137","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5583_CR56","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0022-510X(81)90066-6","volume":"51","author":"A Ohnishi","year":"1981","unstructured":"Ohnishi A, Hirano A (1981) Uncompacted myelin lamellae in dysglobulinemic neuropathy. J Neurol Sci 51(1):131\u2013140","journal-title":"J Neurol Sci"},{"issue":"12","key":"5583_CR57","first-page":"1127","volume":"74","author":"R Hashimoto","year":"2015","unstructured":"Hashimoto R, Koike H, Takahashi M, Ohyama K, Kawagashira Y, Iijima M, Sobue G (2015) Uncompacted myelin lamellae and nodal ion channel disruption in POEMS syndrome. J Neuropathol Exp Neurol 74(12):1127\u20131136","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"5583_CR58","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00005072-199109000-00009","volume":"50","author":"H Yoshikawa","year":"1991","unstructured":"Yoshikawa H, Dyck PJ (1991) Uncompacted inner myelin lamellae in inherited tendency to pressure palsy. J Neuropathol Exp Neurol 50(5):649\u2013657","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"5583_CR59","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jnnp.70.2.232","volume":"70","author":"A Lagueny","year":"2001","unstructured":"Lagueny A, Latour P, Vital A, Le Masson G, Rouanet M, Ferrer X, Vital C, Vandenberghe A (2001) Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J Neurol Neurosurg Psychiatry 70(2):232\u2013235","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"5583_CR60","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2012.03.004","volume":"318","author":"Y Fujinuma","year":"2012","unstructured":"Fujinuma Y, Asahina M, Fukushima T, Katagiri A, Yamanaka Y, Misawa S, Kuwabara S (2012) Preserved autonomic function in patients with POEMS syndrome. J Neurol Sci 318(1\u20132):131\u2013134","journal-title":"J Neurol Sci"},{"issue":"6","key":"5583_CR61","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/jnnp.2010.205369","volume":"82","author":"S Isose","year":"2011","unstructured":"Isose S, Misawa S, Kanai K, Shibuya K, Sekiguchi Y, Nasu S, Fujimaki Y, Noto Y, Nakaseko C, Kuwabara S (2011) POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases. J Neurol Neurosurg Psychiatry 82(6):678\u2013680","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5583_CR62","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","volume":"83","author":"S Nasu","year":"2012","unstructured":"Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, Ohmori S, Mitsuma S, Koga S, Kuwabara S (2012) Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 83(5):476\u2013479","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5583_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jnnp-2018-318514","volume":"90","author":"T Suichi","year":"2019","unstructured":"Suichi T, Misawa S, Sato Y, Beppu M, Sakaida E, Sekiguchi Y, Shibuya K, Watanabe K, Amino H, Kuwabara S (2019) Proposal of new clinical diagnostic criteria for POEMS syndrome. J Neurol Neurosurg Psychiatry 90(2):133\u2013137","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5583_CR64","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/jnnp-2011-301472","volume":"83","author":"ML Mauermann","year":"2012","unstructured":"Mauermann ML, Sorenson EJ, Dispenzieri A, Mandrekar J, Suarez GA, Dyck PJ, Dyck PJ (2012) Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry 83(5):480\u2013486","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5583_CR65","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/jnnp-2020-324012","volume":"92","author":"ES Marsh","year":"2021","unstructured":"Marsh ES, Keddie S, Terris-Prestholt F, D\u2019Sa S, Lunn MP (2021) Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs. J Neurol Neurosurg Psychiatry 92(2):172\u2013176","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"5583_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.10182","volume":"26","author":"JY Sung","year":"2002","unstructured":"Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T (2002) Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve 26(2):189\u2013193","journal-title":"Muscle Nerve"},{"issue":"12","key":"5583_CR67","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/jnnp-2012-304874","volume":"84","author":"Y Sekiguchi","year":"2013","unstructured":"Sekiguchi Y, Misawa S, Shibuya K, Nasu S, Mitsuma S, Iwai Y, Beppu M, Sawai S, Ito S, Hirano S, Nakaseko C, Kuwabara S (2013) Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. J Neurol Neurosurg Psychiatry 84(12):1346\u20131348","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"5583_CR68","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/BF00873980","volume":"243","author":"CC Huang","year":"1996","unstructured":"Huang CC, Chu CC (1996) Poor response to intravenous immunoglobulin therapy in patients with Castleman\u2019s disease and the POEMS syndrome. J Neurol 243(10):726\u2013727","journal-title":"J Neurol"},{"issue":"1","key":"5583_CR69","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00415-018-9110-6","volume":"266","author":"R Brown","year":"2019","unstructured":"Brown R, Ginsberg L (2019) POEMS syndrome: clinical update. J Neurol 266(1):268\u2013277","journal-title":"J Neurol"},{"issue":"1","key":"5583_CR70","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00415-018-9068-4","volume":"266","author":"F Cerri","year":"2019","unstructured":"Cerri F, Falzone YM, Riva N, Quattrini A (2019) An update on the diagnosis and management of the polyneuropathy of POEMS syndrome. J Neurol 266(1):258\u2013267","journal-title":"J Neurol"},{"issue":"1","key":"5583_CR71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","volume":"122","author":"MS Humeniuk","year":"2013","unstructured":"Humeniuk MS, Gertz MA, Lacy MQ, Kyle RA, Witzig TE, Kumar SK, Kapoor P, Lust JA, Hayman SR, Buadi FK, Rajkumar SV, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Dispenzieri A (2013) Outcomes of patients with POEMS syndrome treated initially with radiation. Blood 122(1):68\u201373","journal-title":"Blood"},{"issue":"3","key":"5583_CR72","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.63.3.385","volume":"63","author":"S Kuwabara","year":"1997","unstructured":"Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I (1997) Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 63(3):385\u2013387","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"5583_CR73","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","volume":"117","author":"J Li","year":"2011","unstructured":"Li J, Zhang W, Jiao L, Duan MH, Guan HZ, Zhu WG, Tian Z, Zhou DB (2011) Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 117(24):6445\u20136449","journal-title":"Blood"},{"issue":"19","key":"5583_CR74","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2017-07-795385","volume":"131","author":"C Ohwada","year":"2018","unstructured":"Ohwada C, Sakaida E, Kawajiri-Manako C, Nagao Y, Oshima-Hasegawa N, Togasaki E, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Shimizu N, Misawa S, Iseki T, Kuwabara S, Nakaseko C (2018) Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood 131(19):2173\u20132176","journal-title":"Blood"},{"issue":"11","key":"5583_CR75","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1474-4422(16)30157-0","volume":"15","author":"S Misawa","year":"2016","unstructured":"Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S, Kohara N, Kanda T, Kira J, Hanaoka H, Kuwabara S, Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group (2016) Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 15(11):1129\u201337","journal-title":"Lancet Neurol"},{"issue":"11","key":"5583_CR76","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(10)70068-1","volume":"11","author":"M Delforge","year":"2010","unstructured":"Delforge M, Blad\u00e9 J, Dimopoulos MA, Facon T, Kropff M, Ludwig H, Palumbo A, Van Damme P, San-Miguel JF, Sonneveld P (2010) Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol 11(11):1086\u20131095","journal-title":"Lancet Oncol"},{"issue":"9","key":"5583_CR77","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2169\/internalmedicine.3800-19","volume":"59","author":"T Suichi","year":"2020","unstructured":"Suichi T, Misawa S, Nagashima K, Sato Y, Iwai Y, Katayama K, Sekiguchi Y, Shibuya K, Amino H, Suzuki YI, Tsuneyama A, Nakamura K, Kuwabara S (2020) Lenalidomide treatment for thalidomide-refractory POEMS syndrome: a prospective single-arm clinical trial. Intern Med 59(9):1149\u20131153","journal-title":"Intern Med"},{"issue":"4","key":"5583_CR78","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol 79(4):319\u2013328","journal-title":"Am J Hematol"},{"issue":"8","key":"5583_CR79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s004150170109","volume":"248","author":"D Adams","year":"2001","unstructured":"Adams D (2001) Hereditary and acquired amyloid neuropathies. J Neurol 248(8):647\u2013657","journal-title":"J Neurol"},{"issue":"7","key":"5583_CR80","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams D, Koike H, Slama M, Coelho T (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 15(7):387\u2013404","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"5583_CR81","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/1097-0142(19821015)50:8<1491::AID-CNCR2820500808>3.0.CO;2-Q","volume":"50","author":"C Vital","year":"1982","unstructured":"Vital C, Vallat JM, Deminiere C, Loubet A, Leboutet MJ (1982) Peripheral nerve damage during multiple myeloma and Waldenstrom\u2019s macroglobulinemia: an ultrastructural and immunopathologic study. Cancer 50(8):1491\u20131497","journal-title":"Cancer"},{"issue":"2","key":"5583_CR82","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF00294378","volume":"79","author":"C Sommer","year":"1989","unstructured":"Sommer C, Schr\u00f6der JM (1989) Amyloid neuropathy: immunocytochemical localization of intra- and extracellular immunoglobulin light chains. Acta Neuropathol 79(2):190\u2013199","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5583_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/biomedicines7010011","volume":"7","author":"H Koike","year":"2019","unstructured":"Koike H, Katsuno M (2019) Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights. Biomedicines 7(1):11","journal-title":"Biomedicines"},{"issue":"1","key":"5583_CR84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.22229","volume":"45","author":"S Mathis","year":"2012","unstructured":"Mathis S, Magy L, Diallo L, Boukhris S, Vallat JM (2012) Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 45(1):26\u201331","journal-title":"Muscle Nerve"},{"issue":"9","key":"5583_CR85","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.4049\/jimmunol.162.9.5556","volume":"162","author":"K Hamidi Asl","year":"1999","unstructured":"Hamidi Asl K, Liepnieks JJ, Nakamura M, Benson MD (1999) Organ-specific (localized) synthesis of Ig light chain amyloid. J Immunol 162(9):5556\u20135560","journal-title":"J Immunol"},{"issue":"10","key":"5583_CR86","first-page":"665","volume":"58","author":"RA Kyle","year":"1983","unstructured":"Kyle RA, Greipp PR (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 58(10):665\u201383","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"5583_CR87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2169\/internalmedicine.9206-17","volume":"57","author":"C Shimazaki","year":"2018","unstructured":"Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekijima Y, Ikeda S, Yazaki M, Fukushima W, Ando Y (2018) Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med 57(2):181\u2013187","journal-title":"Intern Med"},{"issue":"1","key":"5583_CR88","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","volume":"63","author":"H Koike","year":"2004","unstructured":"Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, Sobue G (2004) Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63(1):129\u2013138","journal-title":"Neurology"},{"issue":"2","key":"5583_CR89","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40120-020-00210-7","volume":"9","author":"H Koike","year":"2020","unstructured":"Koike H, Katsuno M (2020) Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies. Neurol Ther 9(2):317\u2013333","journal-title":"Neurol Ther"},{"issue":"2","key":"5583_CR90","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","volume":"83","author":"H Koike","year":"2012","unstructured":"Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Fujitake J, Kawanami T, Kato T, Yamamoto M, Sobue G (2012) Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 83(2):152\u2013158","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"5583_CR91","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ajh.25819","volume":"95","author":"MA Gertz","year":"2020","unstructured":"Gertz MA (2020) Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment. Am J Hematol 95(7):848\u2013860","journal-title":"Am J Hematol"},{"key":"5583_CR92","unstructured":"Koike H, Okumura T, Murohara T, Katsuno, M. Multidisciplinary approaches for transthyretin amyloidosis. Cardiol Ther., in press."},{"issue":"2","key":"5583_CR93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/archneurol.2010.261","volume":"68","author":"CJ Klein","year":"2011","unstructured":"Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJ, Spinner RJ, Mauermann ML, Bergen HR 3rd, Zeldenrust SR, Dogan A (2011) Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol 68(2):195\u2013199","journal-title":"Arch Neurol"},{"issue":"4","key":"5583_CR94","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1468-1331.2010.03215.x","volume":"18","author":"M Matsuda","year":"2011","unstructured":"Matsuda M, Gono T, Morita H, Katoh N, Kodaira M, Ikeda S (2011) Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. Eur J Neurol 18(4):604\u2013610","journal-title":"Eur J Neurol"},{"issue":"7778","key":"5583_CR95","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0140-6736(72)93014-0","volume":"2","author":"NF Jones","year":"1972","unstructured":"Jones NF, Hilton PJ, Tighe JR, Hobbs JR (1972) Treatment of \u201cprimary\u201d renal amyloidosis with melphalan. Lancet 2(7778):616\u2013619","journal-title":"Lancet"},{"issue":"17","key":"5583_CR96","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","volume":"336","author":"RA Kyle","year":"1997","unstructured":"Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, Therneau TM (1997) A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336(17):1202\u20131207","journal-title":"N Engl J Med"},{"issue":"7","key":"5583_CR97","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1182\/blood.V88.7.2801.bloodjournal8872801","volume":"88","author":"RL Comenzo","year":"1996","unstructured":"Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K, Dubrey S, Faller DV, Wright DG, Falk RH, Skinner M (1996) Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood 88(7):2801\u20132806","journal-title":"Blood"},{"issue":"11","key":"5583_CR98","doi-asserted-by":"publisher","first-page":"1083 93","DOI":"10.1056\/NEJMoa070484","volume":"357","author":"A Jaccard","year":"2007","unstructured":"Jaccard A, Moreau P, Leblond V, Leleu X, Benboubker L, Hermine O, Recher C, Asli B, Lioure B, Royer B, Jardin F, Bridoux F, Grosbois B, Jaubert J, Piette JC, Ronco P, Quet F, Cogne M, Fermand JP (2007) My\u00e9lome Autogreffe (MAG) and Intergroupe Francophone du My\u00e9lome (IFM) Intergroup. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 357(11):1083 93","journal-title":"N Engl J Med"},{"issue":"14","key":"5583_CR99","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/cncr.30051","volume":"122","author":"MA Gertz","year":"2016","unstructured":"Gertz MA, Lacy MQ, Dispenzieri A, Buadi FK, Dingli D, Hayman SR, Kumar SK, Leung N, Lust J, Rajkumar SV, Russell SJ, Suman VJ, Le-Rademacher JG, Hogan WJ (2016) Stem cell transplantation compared with melphalan plus dexamethasone in the treatment of immunoglobulin light-chain amyloidosis. Cancer 122(14):2197\u20132205","journal-title":"Cancer"},{"issue":"2","key":"5583_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jns.12381","volume":"25","author":"L Obici","year":"2020","unstructured":"Obici L, Adams D (2020) Acquired and inherited amyloidosis: knowledge driving patients\u2019 care. J Peripher Nerv Syst 25(2):85\u2013101","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"5583_CR101","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCHEARTFAILURE.108.788687","volume":"1","author":"A Biolo","year":"2008","unstructured":"Biolo A, Ramamurthy S, Connors LH, O\u2019Hara CJ, Meier-Ewert HK, Soo Hoo PT, Sawyer DB, Seldin DC, Sam F (2008) Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition. Circ Heart Fail 1(4):249\u2013257","journal-title":"Circ Heart Fail"},{"issue":"25","key":"5583_CR102","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.1182\/blood-2011-04-351643","volume":"118","author":"JE Ward","year":"2011","unstructured":"Ward JE, Ren R, Toraldo G, Soohoo P, Guan J, O\u2019Hara C, Jasuja R, Trinkaus-Randall V, Liao R, Connors LH, Seldin DC (2011) Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis. Blood 118(25):6610\u20136617","journal-title":"Blood"},{"issue":"8","key":"5583_CR103","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.conctc.2017.08.012","volume":"24","author":"A D\u2019Souza","year":"2017","unstructured":"D\u2019Souza A, Flynn K, Chhabra S, Dhakal B, Hamadani M, Jacobsen K, Pasquini M, Weihrauch D, Hari P (2017) Rationale and design of DUAL study: doxycycline to upgrade response in light chain (AL) amyloidosis (DUAL): a phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis. Contemp Clin Trials Commun 24(8):33\u201338","journal-title":"Contemp Clin Trials Commun"},{"issue":"10","key":"5583_CR104","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1161\/CIRCRESAHA.121.318187","volume":"128","author":"JM Griffin","year":"2021","unstructured":"Griffin JM, Rosenblum H, Maurer MS (2021) Pathophysiology and therapeutic approaches to cardiac amyloidosis. Circ Res 128(10):1554\u20131575","journal-title":"Circ Res"},{"issue":"4","key":"5583_CR105","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0002-9440(10)64639-1","volume":"157","author":"R Hrncic","year":"2000","unstructured":"Hrncic R, Wall J, Wolfenbarger DA, Murphy CL, Schell M, Weiss DT, Solomon A (2000) Antibody-mediated resolution of light chain-associated amyloid deposits. Am J Pathol 157(4):1239\u20131246","journal-title":"Am J Pathol"},{"issue":"5","key":"5583_CR106","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ana.410230517","volume":"23","author":"E Nardelli","year":"1988","unstructured":"Nardelli E, Steck AJ, Barkas T, Schluep M, Jerusalem F (1988) Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b. Ann Neurol 23(5):524\u2013528","journal-title":"Ann Neurol"},{"issue":"10","key":"5583_CR107","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1212\/WNL.57.10.1909","volume":"57","author":"M Eurelings","year":"2001","unstructured":"Eurelings M, Ang CW, Notermans NC, Van Doorn PA, Jacobs BC, Van den Berg LH (2001) Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 57(10):1909\u20131912","journal-title":"Neurology"},{"issue":"3","key":"5583_CR108","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00415-014-7612-4","volume":"262","author":"L Vlam","year":"2015","unstructured":"Vlam L, Piepers S, Sutedja NA, Jacobs BC, Tio-Gillen AP, Stam M, Franssen H, Veldink JH, Cats EA, Notermans NC, Bloem AC, Wadman RI, van der Pol WL, van den Berg LH (2015) Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study. J Neurol 262(3):666\u2013673","journal-title":"J Neurol"},{"issue":"2","key":"5583_CR109","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0022-510X(00)00342-7","volume":"176","author":"M Carpo","year":"2000","unstructured":"Carpo M, Meucci N, Allaria S, Marmiroli P, Monaco S, Toscano A, Simonetti S, Scarlato G, Nobile-Orazio E (2000) Anti-sulfatide IgM antibodies in peripheral neuropathy. J Neurol Sci 176(2):144\u2013150","journal-title":"J Neurol Sci"},{"issue":"7","key":"5583_CR110","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1212\/WNL.54.7.1448","volume":"54","author":"R Dabby","year":"2000","unstructured":"Dabby R, Weimer LH, Hays AP, Olarte M, Latov N (2000) Antisulfatide antibodies in neuropathy: clinical and electrophysiologic correlates. Neurology 54(7):1448\u20131452","journal-title":"Neurology"},{"issue":"8","key":"5583_CR111","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1468-1331.2010.03345.x","volume":"18","author":"S Mat\u00e0","year":"2011","unstructured":"Mat\u00e0 S, Borsini W, Ambrosini S, Toscani L, Barilaro A, Piacentini S, Sorbi S, Lolli F (2011) IgM monoclonal gammopathy-associated neuropathies with different IgM specificity. Eur J Neurol 18(8):1067\u20131073","journal-title":"Eur J Neurol"},{"issue":"281","key":"5583_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.009","volume":"15","author":"M Campagnolo","year":"2015","unstructured":"Campagnolo M, Ferrari S, Dalla Torre C, Cabrini I, Cacciavillani M, Lucchetta M, Ruggero S, Toffanin E, Cavallaro T, Briani C (2015) Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment. J Neuroimmunol 15(281):1\u20134","journal-title":"J Neuroimmunol"},{"issue":"11","key":"5583_CR113","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/ene.13387","volume":"24","author":"F Boso","year":"2017","unstructured":"Boso F, Ruggero S, Giannotta C, Benedetti L, Marfia GA, Ermani M, Campagnolo M, Salvalaggio A, Gallia F, De Michelis C, Visentin A, Bianco M, Ruiz M, Mataluni G, Nobile-Orazio E, Briani C (2017) Anti-sulfatide\/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies. Eur J Neurol 24(11):1334\u20131340","journal-title":"Eur J Neurol"},{"issue":"Pt 10","key":"5583_CR114","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","volume":"124","author":"HJ Willison","year":"2001","unstructured":"Willison HJ, O\u2019Leary CP, Veitch J, Blumhardt LD, Busby M, Donaghy M, Fuhr P, Ford H, Hahn A, Renaud S, Katifi HA, Ponsford S, Reuber M, Steck A, Sutton I, Schady W, Thomas PK, Thompson AJ, Vallat JM, Winer J (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 124(Pt 10):1968\u20131977","journal-title":"Brain"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05583-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T22:04:17Z","timestamp":1699481057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05583-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":114,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5583"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05583-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review article and ethical approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}